Arabic Ages and Stages Questionnaire-III

Sponsor
American University of Beirut Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02539251
Collaborator
(none)
527
1
75
7

Study Details

Study Description

Brief Summary

Early detection and intervention for developmental delays are crucial in promoting healthy child development, hence the need for formal screening. In the Arabic speaking population developmental screening tools are scarce in the native language and there is a need for such a tool for pediatricians and health care workers to use routinely.

This study aims to translate, adapt and validate the newest version of ASQ (ASQ-3) to Arabic (A-ASQ-3) based on the previously published study showing that ASQ-2 was culturally sensitive.

The previously translated A-ASQ-2 will be revised and updated to match the new ASQ-3, then revised by experts in child development. Questionnaires will be adapted and field-tested on 15 subjects per age group (total of 75). For validity, the revised version will be tested on 500 Lebanese children (100 children per age group) selected from all Lebanese governates.

It is expected to generate a culturally adapted and validated Arabic tool for screening children for any developmental delay up to 3 years of age. This tool once published will be available for use by primary care providers and caregivers in Arabic speaking countries. It may be used to screen children for developmental delay as early as 7 months therefore prompting prevention of further delay by starting early intervention and promoting child development.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Arabic ASQ -3

Detailed Description

The Ages and Stages Questionnaires (ASQ) is a developmental screening questionnaire for parents to answer regarding their children's level of growth and development between the ages of 7 months and 3 years. This questionnaire was translated into Arabic in order to adapt it for the Arab speaking culture. For the first phase of this study, aiming to adapt and field-test this translated version, parents of eligible children will be recruited from the AUBMC outpatient clinics (OPD and Private Clinics). Interested parents of eligible children will be invited to a private meeting in private settings where the study will be thoroughly explained. 75 parents (fathers or mothers) will be interviewed and asked to answer the ASQ.

At a later stage, 500 parents will be interviewed and asked to answer the ASQ in order to test its validity. A list of all day care centers in Lebanon will be retrieved from the ministry of public health website and a list of all Lebanese pediatricians will be sought from the both Lebanese Order of Physicians (Beirut and Tripoli). Eligible day cares are the ones with at least 15 children between 7 and 36 months. Eligible physicians are those who are actively seeing patients aged between 7 and 36 months with a patient load of at least 10 per day.

To minimize selection bias and to include different socioeconomic groups, a random sample of eligible day care centers and pediatricians from across the Lebanese governorates (Beirut, Mount Lebanon, South Lebanon, North Lebanon and Beqaa) will be selected.

After obtaining the permission of the selected day care centers and pediatricians, flyers explaining the study and inviting parents to participate will be distributed and posted at those centers. Parents of eligible children who contact us and show interest in participating will be invited for a meeting in private settings. Construct validation will be done using varimax rotation, concurrent validity will be done by correlating ASQ-3 scores with Bayley scale for infant development scores. Sensitivity and specificity will also be tested.

Parents will be asked some questions regarding their child's growth in order to evaluate several aspects of his/her developmental skills. It takes 10-15 minutes to complete the questionnaires. After completing the questionnaire, the child's developmental status will be evaluated and any risk of delay will be detected.

Study Design

Study Type:
Observational
Actual Enrollment :
527 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Adaptation and Validation of the Ages and Stages Questionnaires -3 (ASQ-3) in Arabic
Study Start Date :
Sep 1, 2015
Actual Primary Completion Date :
Dec 1, 2018
Actual Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Validation of Arabic ASQ-3

This group of patients will serve as a reference for validation of the Arabic ASQ-3

Behavioral: Arabic ASQ -3
Administration of a developmental questionnaire in Arabic (A-ASQ-3) and validation using BSID-III as a gold standard

Outcome Measures

Primary Outcome Measures

  1. Adapt and validate Arabic ASQ by measuring construct validity (varimax rotation), concurrent validity by correlating ASQ-3 scores with BSID-III scores and computing sensitivity and specificity taking BSID-III as gold standard. [2 years]

    After cultural adaptation, Arabic ASQ-3 will be validated by measuring construct validity using varimax rotation, concurrent validity by correlating ASQ-3 scores with Bayley scale for infant development scores and by computing the Arabic ASQ-3 sensitivity and specificity taking BSID-III as gold standard.

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Months to 3 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Adaptation:
  • Arabic speaking parents of children between the ages of 4 months and 3 years
Validation:
  • Children between 4 months and 3 years of age in chosen day care centers

  • Children between 4 months and 3 years of age presenting to their pediatricians offices for well child check up.

Exclusion Criteria:
  • Children with known severe disability

  • Children with chronic condition that might interfere with the developmental testing (blindness, deafness, congenital hypothyroidism, severe mental disability)

Contacts and Locations

Locations

Site City State Country Postal Code
1 American University of Beirut Beirut Lebanon 1107 2020

Sponsors and Collaborators

  • American University of Beirut Medical Center

Investigators

  • Principal Investigator: Lama Charafeddine, MD FAAP, American University of Beirut Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Lama Charafeddine, Assistant Professor of Clinical Pediatrics Fellowship Program, MD FAAP, American University of Beirut Medical Center
ClinicalTrials.gov Identifier:
NCT02539251
Other Study ID Numbers:
  • PED.LC.07
First Posted:
Sep 3, 2015
Last Update Posted:
Feb 17, 2022
Last Verified:
Feb 1, 2022
Keywords provided by Lama Charafeddine, Assistant Professor of Clinical Pediatrics Fellowship Program, MD FAAP, American University of Beirut Medical Center

Study Results

No Results Posted as of Feb 17, 2022